Volume 21, Issue 8, Pages (August 2013)

Slides:



Advertisements
Similar presentations
Volume 18, Issue 2, Pages (February 2010)
Advertisements

Volume 23, Issue 12, Pages (December 2015)
Structural Basis for the Highly Selective Inhibition of MMP-13
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Ping Wang, Katelyn A. Doxtader, Yunsun Nam  Molecular Cell 
Volume 25, Issue 8, Pages e4 (August 2017)
Volume 15, Issue 8, Pages (August 2007)
Volume 21, Issue 9, Pages (September 2013)
Tamas Yelland, Snezana Djordjevic  Structure 
Volume 16, Issue 10, Pages (October 2008)
Mark Ultsch, Nathalie A Lokker, Paul J Godowski, Abraham M de Vos 
Allosteric Effects of the Oncogenic RasQ61L Mutant on Raf-RBD
Volume 16, Issue 10, Pages (October 2008)
Volume 23, Issue 7, Pages (July 2015)
Volume 23, Issue 5, Pages (May 2015)
Volume 25, Issue 5, Pages e3 (May 2017)
Volume 20, Issue 5, Pages (May 2012)
The Mechanism of E. coli RNA Polymerase Regulation by ppGpp Is Suggested by the Structure of their Complex  Yuhong Zuo, Yeming Wang, Thomas A. Steitz 
How Does a Voltage Sensor Interact with a Lipid Bilayer
Rong Shi, Laura McDonald, Miroslaw Cygler, Irena Ekiel  Structure 
Structural Basis of DNA Loop Recognition by Endonuclease V
Volume 25, Issue 5, Pages e3 (May 2017)
Volume 18, Issue 9, Pages (September 2010)
Volume 11, Issue 5, Pages (May 2003)
Elif Eren, Megan Murphy, Jon Goguen, Bert van den Berg  Structure 
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 21, Issue 10, Pages (October 2013)
Volume 14, Issue 2, Pages (February 2006)
Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Catalysis  Marcin Nowotny, Sergei A. Gaidamakov, Robert.
Structural Basis for the Differential Effects of CaBP1 and Calmodulin on CaV1.2 Calcium-Dependent Inactivation  Felix Findeisen, Daniel L. Minor  Structure 
Volume 25, Issue 5, Pages e3 (May 2017)
Volume 16, Issue 5, Pages (May 2008)
Structural Insights into Ligand Recognition by a Sensing Domain of the Cooperative Glycine Riboswitch  Lili Huang, Alexander Serganov, Dinshaw J. Patel 
Structural Basis of Prion Inhibition by Phenothiazine Compounds
Structural Roles of Monovalent Cations in the HDV Ribozyme
Volume 9, Issue 8, Pages (August 2001)
Elizabeth J. Little, Andrea C. Babic, Nancy C. Horton  Structure 
Volume 33, Issue 2, Pages (January 2009)
Volume 25, Issue 8, Pages e4 (August 2017)
Volume 17, Issue 10, Pages (October 2009)
Volume 23, Issue 4, Pages (April 2015)
Crystal Structure of the Borna Disease Virus Nucleoprotein
Volume 20, Issue 2, Pages (February 2013)
Crystal Structure of the p53 Core Domain Bound to a Full Consensus Site as a Self- Assembled Tetramer  Yongheng Chen, Raja Dey, Lin Chen  Structure  Volume.
Antonina Roll-Mecak, Chune Cao, Thomas E. Dever, Stephen K. Burley 
Structural Basis for the Highly Selective Inhibition of MMP-13
Insights into Oncogenic Mutations of Plexin-B1 Based on the Solution Structure of the Rho GTPase Binding Domain  Yufeng Tong, Prasanta K. Hota, Mehdi.
The basis for K-Ras4B binding specificity to protein farnesyl-transferase revealed by 2 Å resolution ternary complex structures  Stephen B Long, Patrick.
Volume 17, Issue 10, Pages (October 2009)
Paolo A. Lobo, Lynn Kimlicka, Ching-Chieh Tung, Filip Van Petegem 
Volume 23, Issue 6, Pages (June 2015)
Tianjun Zhou, Liguang Sun, John Humphreys, Elizabeth J. Goldsmith 
A Role for Intersubunit Interactions in Maintaining SAGA Deubiquitinating Module Structure and Activity  Nadine L. Samara, Alison E. Ringel, Cynthia Wolberger 
Volume 18, Issue 9, Pages (September 2010)
Volume 24, Issue 9, Pages (September 2016)
Volume 26, Issue 3, Pages e4 (March 2018)
DNA Synthesis across an Abasic Lesion by Human DNA Polymerase ι
Structure of the Staphylococcus aureus AgrA LytTR Domain Bound to DNA Reveals a Beta Fold with an Unusual Mode of Binding  David J. Sidote, Christopher.
Volume 17, Issue 7, Pages (July 2009)
Structural and Biochemical Mechanisms for the Specificity of Hormone Binding and Coactivator Assembly by Mineralocorticoid Receptor  Yong Li, Kelly Suino,
Robert S. Magin, Glen P. Liszczak, Ronen Marmorstein  Structure 
Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Catalysis  Marcin Nowotny, Sergei A. Gaidamakov, Robert.
Volume 13, Issue 5, Pages (May 2005)
Volume 24, Issue 3, Pages (March 2016)
Structural Basis for Ligand Binding to the Guanidine-I Riboswitch
Structural and Thermodynamic Basis for Enhanced DNA Binding by a Promiscuous Mutant EcoRI Endonuclease  Paul J. Sapienza, John M. Rosenberg, Linda Jen-Jacobson 
Petra Hänzelmann, Hermann Schindelin  Structure 
Volume 23, Issue 12, Pages (December 2015)
Volume 20, Issue 5, Pages (May 2012)
Robert S. Magin, Glen P. Liszczak, Ronen Marmorstein  Structure 
Presentation transcript:

Volume 21, Issue 8, Pages 1440-1449 (August 2013) The Cardiac Ryanodine Receptor N-Terminal Region Contains an Anion Binding Site that Is Targeted by Disease Mutations  Lynn Kimlicka, Ching-Chieh Tung, Anna-Carin Cecilia Carlsson, Paolo Antonio Lobo, Zhiguang Yuchi, Filip Van Petegem  Structure  Volume 21, Issue 8, Pages 1440-1449 (August 2013) DOI: 10.1016/j.str.2013.06.012 Copyright © 2013 Elsevier Ltd Terms and Conditions

Structure 2013 21, 1440-1449DOI: (10.1016/j.str.2013.06.012) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 1 Overall Structure of the RyR2 N-Terminal Region (A) Cartoon representation of mouse RyR2 residues 1–547 (RyR2ABC). Blue, domain A; green, domain B; red, domain C. Select secondary structure elements are labeled. (B) Superposition of RyR1ABC (gray) and RyR2ABC (colors). (C) Thermal melting curves indicating thermal stability. The melting temperatures, obtained by taking the maxima of the first derivatives, are 48.0°C ± 0°C (RyR1ABC), 43.1°C ± 0.4°C (RyR2ABC), and 42.3°C ± 1.4°C (RyR2ABC R420Q) (errors indicating SD of the mean). The RyR2ABC wild-type (WT) and mutant melting curves show two transitions, but due to the shallow nature of the second transition, a melting temperature for this portion could not be obtained reliably. See also Figure S1. Structure 2013 21, 1440-1449DOI: (10.1016/j.str.2013.06.012) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 2 Details of the Anion Binding Site (A) Interdomain interaction area for RyR1ABC showing the salt-bridge network involving residues in all three domains. Black dashed lines indicate hydrogen bonds between ionic pairs. Orange dashed lines indicate a salt bridge between Arg283 and Asp61 that is not formed by hydrogen bonds. (B) The corresponding region in RyR2ABC. Domains are colored as in Figure 1. Fo − Fc density, contoured at 3 σ, is shown for the chloride site. Dashed lines indicate contacts with positively charged arginine atoms and a hydrogen bond between Tyr125 and Arg420. Two histidine residues in RyR1 are replaced by Arg 420 and Tyr125. This results in a disruption of the ionic pair network and the creation of a chloride binding site. Arg298 and Asp61 form a salt bridge that is not mediated by hydrogen bonds. (C) Surface representation of RyR2ABC, with the chloride ion shown as a black sphere. The chloride is inaccessible to solvent. (D) Anomalous difference maps for the bromide-bound structure, contoured at 7 σ (outer mesh) and 20 σ (inner mesh). The peak is visible up to 34 σ. See also Figure S2. Structure 2013 21, 1440-1449DOI: (10.1016/j.str.2013.06.012) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 3 Structure of the R420Q Disease Mutant (A) Crystal structure of the R420Q disease mutant (gray) superposed on the WT RyR2ABC structure (colors). No chloride density was visible for the disease mutant. (B and C) Superposition of WT (colors) and R420Q RyR2ABC (white) based on domain C showing the relative positions of domains A (B) and B (C). Shifts in the domain arrangement are indicated by arrows. Domains A and B are shifted relative to domain C. (D) Superposition of WT and R420Q based on domain A showing a near-perfect superposition of domain B, indicating the relative orientation of domain A versus B is unchanged. See also Figure S3. Structure 2013 21, 1440-1449DOI: (10.1016/j.str.2013.06.012) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 4 Additional RyR2 Disease Mutants Domains are colored according to Figure 1. (A) Mapping of known disease mutations on the RyR2ABC structure, with the target residues shown as black sticks. Exon 3 is shown in black cartoon representation. (B) Detail of several exon 3 residues (black) interacting with domain B. (C–F) Details of the environments of four disease mutation target sites for which purification was attempted. The mutated residue is shown in black sticks. All four caused destabilization of the protein, resulting in heavily degraded material. Shown are positions of L62F (C), F329L (D), T415R (E), and L433P (F). Structure 2013 21, 1440-1449DOI: (10.1016/j.str.2013.06.012) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 5 PEG Binding Sites (A) Surface representation of RyR2ABC, showing two binding pockets for short polyethylene glycol molecules. Coloring is according to Figure 1. Weighted 2Fo − Fc density is shown in black mesh, contoured at 1 σ. The view is from the “bottom” compared to Figure 1, as viewed from the ER/SR lumen toward the cytosol. (B) Details of the two binding pockets, showing all residues within 4 Å. The chloride ion (sphere, not within 4 Å) is shown for reference. Structure 2013 21, 1440-1449DOI: (10.1016/j.str.2013.06.012) Copyright © 2013 Elsevier Ltd Terms and Conditions